A six month collaborative project between the Cell and Gene Therapy Catapult (CGT Catapult) and the National Institute of Biological Standards and Control (NIBSC) has been announced which will result in preparing the first reference material of an Adenovirus-associated vector that will be globally available to facilitate harmonisation of modern analytics. The AAV reference material will be manufactured at the newly setup CGT Catapult’s state-of-the art facility in Braintree. Source: C&GT Catapult press release 16/9/2021